Proposal Brief
Industry
Pharmaceuticals
Sub Industry
Integrated
Deal Size
INR 100 - 200 Cr
Preferred Location
India
Region
Northern
Open for Distressed Assets
Yes
Target Requirement
A pharmaceutical client is looking out for acquiring a GMP / MHRA approved/certified Formulation plant having a capacity of approx 200-250 MT per month and an API plant having capacity of producing volume building API’s ( paracetamol, ibuprofen, Metformin) of around 300 – 500 MT per month anywhere in India. The firm has established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliance. The Plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development.
